Clinical Trials Browser

Phase 2 × tetrathiomolybdate × 1 year × Clear all

NCT00195091 2025-05-16

Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer

Phase 2 Terminated

16 enrolled 5 charts

Breast Neoplasms